HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.

Abstract
1 The effects of YM-254890, a specific Galpha(q/11) inhibitor, on platelet functions, thrombus formation under high-shear rate condition and femoral artery thrombosis in cynomolgus monkeys were investigated. 2 YM-254890 concentration dependently inhibited ADP-induced intracellular Ca(2+) elevation, with an IC(50) value of 0.92+/-0.28 microM. 3 P-selectin expression induced by ADP or thrombin receptor agonist peptide (TRAP) was strongly inhibited by YM-254890, with IC(50) values of 0.51+/-0.02 and 0.16+/-0.08 microM, respectively. 4 YM-254890 had no effect on the binding of fibrinogen to purified GPIIb/IIIa, but strongly inhibited binding to TRAP-stimulated washed platelets. 5 YM-254890 completely inhibited platelet shape change induced by ADP, but not that induced by collagen, TRAP, arachidonic acid, U46619 or A23187. 6 YM-254890 attenuated ADP-, collagen-, TRAP-, arachidonic acid- and U46619-induced platelet aggregation with IC(50) values of <1 microM, whereas it had no effect on phorbol 12-myristate 13-acetate-, ristocetin-, thapsigargin- or A23187-induced platelet aggregation. 7 High-shear stress-induced platelet aggregation and platelet-rich thrombus formation on a collagen surface under high-shear flow conditions were concentration dependently inhibited by YM-254890. 8 The antithrombotic effect of YM-254890 was evaluated in a model of cyclic flow reductions in the femoral artery of cynomolgus monkeys. The intravenous bolus injection of YM-254890 dose dependently inhibited recurrent thrombosis without affecting systemic blood pressure or prolonging template bleeding time. 9 YM-254890 is a useful tool for investigating Galpha(q/11)-coupled receptor signaling and the physiological roles of Galpha(q/11).
AuthorsToshio Uemura, Tomihisa Kawasaki, Masatoshi Taniguchi, Yumiko Moritani, Kazumi Hayashi, Tetsu Saito, Jun Takasaki, Wataru Uchida, Keiji Miyata
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 148 Issue 1 Pg. 61-9 (May 2006) ISSN: 0007-1188 [Print] England
PMID16520742 (Publication Type: Journal Article)
Chemical References
  • Fibrinolytic Agents
  • P-Selectin
  • Peptides, Cyclic
  • Platelet Aggregation Inhibitors
  • Receptors, Thrombin
  • YM-254890
  • Adenosine Diphosphate
  • Fibrinogen
  • GTP-Binding Protein alpha Subunits, Gq-G11
  • Calcium
Topics
  • Adenosine Diphosphate
  • Animals
  • Blood Platelets (cytology, drug effects, metabolism)
  • Calcium (metabolism)
  • Cell Shape
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Femoral Artery (drug effects, physiopathology, surgery)
  • Fibrinogen (metabolism)
  • Fibrinolytic Agents (pharmacology)
  • GTP-Binding Protein alpha Subunits, Gq-G11 (antagonists & inhibitors, metabolism)
  • Ligation
  • Macaca fascicularis
  • P-Selectin (metabolism)
  • Peptides, Cyclic (pharmacology)
  • Platelet Aggregation
  • Platelet Aggregation Inhibitors (pharmacology)
  • Receptors, Thrombin
  • Regional Blood Flow
  • Stress, Mechanical
  • Thrombosis (metabolism, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: